Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)

Clinical trial NCT05751668 · SUSPENDED

Trial details

NCT number: NCT05751668
Sponsor: Alliance for Clinical Trials in Oncology
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Chemotherapy-Induced Peripheral Neuropathy Metastatic Breast Carcinoma

Start date: 2023-11-02
Primary completion: 2028-03-15
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.